Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.07 USD | +0.44% | +4.33% | -15.07% |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 406M | Capitalization | 1.18B |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.44 x |
Net cash position 2024 * | 93.72M | Net cash position 2025 * | 88.72M | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
-18.9
x | P/E ratio 2025 * |
480
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | +0.44% | ||
1 week | +4.33% | ||
Current month | +4.33% | ||
1 month | +0.12% | ||
3 months | -10.94% | ||
6 months | -23.71% | ||
Current year | -15.07% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 25.07 | +0.44% | 641,569 |
24-06-06 | 24.96 | -5.10% | 412,667 |
24-06-05 | 26.3 | +1.98% | 732,602 |
24-06-04 | 25.79 | +1.74% | 793,904 |
24-06-03 | 25.35 | +5.49% | 1,123,864 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.07% | 1.18B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- MIRM Stock